Research in the life sciences sector takes place in most cases across national borders. Personal data is being shared from the setup of a research project to the final solution, therapy or product. Especially after the latest rulings at the European Court of Justice in 2020 (Schrems II) the transfer of this data is an enormous challenge. Whether the Standard Contractual Clauses (STC) of 2021 will be able to solve the data protection issues after the EU-US Privacy Shield has been invalidated is to be discussed.

Focus

Legal Aspects of International Research and Development with Genomic Data
Thomas Szucs

• Genetic data in the life sciences
• Research meets Law – rules and regulations of genetic data
• Development and challenges for researchers, patients and companies

Legal Challenges of Cross-Border Data Transfers in International Research Cooperation after Schrems II
Claudia Seitz

• Impact and Legal Challenges of Cross-Border Data Transfers after the ECJ´s Schrems II Judgment
• Navigating Cross-Border Data Transfers in the Pharmaceutical Sector after the Invalidation of the EU-US Privacy Shield Framework
• Legal Analsys of Standard Contractual Clauses (SCCs)

Cross-Border Data Transfers after Schrems II – Practical Steps for Organizations
Elvira Valverde Garcia

• Analysis and reactions of the Schrems II judgment in the pharmaceutical sector
• Practical steps for organizations to comply with Schrems II judgment
• Practical examples and recommendations on how these challenges could be addressed